MedTrace Logo

Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations

NCT04558307 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2021-07-13

No results posted yet for this study

Summary

The purpose of this study is to assess the feasibility of establishing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing at a federally-qualified health center (FQHC) during a global health crisis to mitigate COVID-19 disparities in socioeconomically disadvantaged populations.

Conditions

  • Coronavirus Disease (COVID-19)

Interventions

DIAGNOSTIC_TEST

Pilot a rapid SARS-CoV-2 testing strategy

Rapid testing strategy at an FQHC using Mayo Clinic Laboratory (MCL) diagnostic processing with a real-time polymerase chain reaction assay for SARS-CoV-2 and a Mayo Clinic drive-through collection protocol.

OTHER

Community-driven messages to promote COVID-19 testing

A one-time communication about the availability of COVID-19 testing at the FQHC to patients randomized to the intervention group using any available means of communication (text and/or mailed letter).

Sponsors & Collaborators

Principal Investigators

  • LaPrincess C Brewer, MD, MPH · Mayo Clinic

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-03
Primary Completion
2021-06-01
Completion
2021-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04558307 on ClinicalTrials.gov